1 withdrawn. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Withdrawn 1 |
Follow Manganese Safety in Pediatric Patients: new trials by email Literature Review of Manganese Safety in Pediatric Patients trials Research Report on Manganese Safety in Pediatric Patients
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-term PN Tralement, Fixed-dose trace element combination product of zinc, copper, and selenious acid - Manganese Safety in Pediatric Patients | Phase 4 | Withdrawn | American Regent, Inc. | 2024-08-01 | 2024-11-15 |
Copper (1) · Copper Sulfate (1) · Selenious Acid (1) · Trace Elements (1) · Zinc Sulfate (1) · manganese sulfate (1)
Mark Falone, MD (1)